the handling question that gets asked weekly, answered properly
The title is the argument: the handling question that gets asked weekly, answered properly. Here is the rest of it.
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.
best — the order this archive was captured in
Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
[deleted]
Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.
For any compound with a thin testing history, identity is the first question.
batch_number_bertie is right that a purity figure without a method is not comparable to one with a method.
research-use-only material is not approved for human use
the sequence is the product, everything else is packaging
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
Left up. Identity-first reasoning with a method stated, which is the standard for this board.
Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.
Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.
Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.
Correction: that name covers two different molecules and the thread has been discussing both as one.
Asked QSC which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.
ask what the reference standard was
identity before purity, every time, for anything unusual
That method was developed for a different compound class and would not resolve the impurities you are asking about.
- 1For any compound with a thin testing history, identity is the first…6 comments in this branch · started by u/batch_number_bertie